Thursday, July 9, 2026

pharma · Endometrial Cancer · WHWK

Whitehawk Therapeutics

Whitehawk Therapeutics patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Morristown, USA HQ
24 Employees
Public company Type
WHWK · NYSE Ticker
Company details
Status
Public
HQ
Morristown, USA
Employees
24
Programs
1
Drugs
0
Patents
0
Intelligence · Patents

Whitehawk Therapeutics patents

0 pharmaceutical patents indexed for Whitehawk Therapeutics. 0 expire within 24 months.

Whitehawk Therapeutics has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

No patents matched

Try a different expiry filter or check back as we index more USPTO records.

Frequently asked questions

How many patents does Whitehawk Therapeutics have?

0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Whitehawk Therapeutics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.